A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
Andrew TannousAndrew P BradfordKatherine KuhnAngela FoughtIrene E SchauerKatherine KuhnPublished in: PloS one (2021)
Acute infusion of lipid and insulin, to mimic the metabolic syndrome of obesity, was not associated with an increase in inflammatory markers. These results imply that the endocrine disruption and adverse reproductive outcomes of obesity are not a consequence of the ambient inflammatory environment but may be mediated by direct lipotoxic effects on the hypothalamic-pituitary-ovarian (HPO) axis.
Keyphrases
- metabolic syndrome
- insulin resistance
- weight loss
- type diabetes
- high fat diet induced
- weight gain
- polycystic ovary syndrome
- high fat diet
- drug induced
- glycemic control
- oxidative stress
- liver failure
- uric acid
- air pollution
- body mass index
- particulate matter
- high glucose
- low dose
- cardiovascular risk factors
- adipose tissue
- physical activity
- study protocol
- skeletal muscle
- respiratory failure
- open label
- cardiovascular disease
- clinical trial
- fatty acid
- case report
- intensive care unit
- cervical cancer screening
- mechanical ventilation
- extracorporeal membrane oxygenation
- stress induced